Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Exploratory Study on the Safety and Efficacy of BEN301 Injection in the Treatment of Autoimmune Diseases

NCT07502859 is registered in ClinicalTrials.gov with Beijing Boren Hospital as lead sponsor.

NCT NCT07502859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07502859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Exploratory Study on the Safety and Efficacy of BEN301 Injection in the Treatment of Autoimmune Diseases
Lead sponsor
Beijing Boren Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
March 25, 2026
Completion date
February 28, 2029
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ssc ra ss iim